Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine

Movement Disorders

Volumn 27, Issue 2, 2012, Pages 326-327

  Walsh, R A ^a   Lang, A E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE;

COMPULSION; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSKINESIA; FRONTAL CORTEX; HIGH RISK PATIENT; HUMAN; IMPULSE CONTROL DISORDER; LETTER; LIBIDO; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUAL BEHAVIOR;

AMANTADINE; ANTIPARKINSON AGENTS; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; MIDDLE AGED; PARKINSON DISEASE;

EID: 84856976416     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23964     Document Type: Letter

References (6)

1. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-595.
2. Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M. Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol 2010; 68: 400-404.
3. Weintraub D, Sohr M, Potenza MN, et al. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol 2010; 68: 963-968.
4. Weintraub D, Hoops S, Shea JA, et al. Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease. Mov Disord 2009; 24: 1461-1467.
5. Shaffer HJ, LaBrie R, Scanlan KM, Cummings TN. Pathological gambling among adolescents: Massachusetts Gambling Screen (MAGS). J Gambl Stud 1994; 10: 339-362.
6. Voon V, Thomsen T, Miyasaki JM, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007; 64: 212-216.